messag updat estim follow
result reduc price target increas
price target
reduc price-to-earnings target multipl
revenu estim move
respect
increas price-to-earnings target multipl
revenu estim move
respect
page analyst certif import disclosur
exhibit valuat risk
lower pt base lower ep multipl
lower multipl valu closer mid-rang peer biotech compani believ
accur reflect somewhat weaker soliri sale potenti revenu hit ahu patient switch ultomiri
soliri
pt assum alexion trade mean similar stage compani ep estim
support risk-adjust npv
forward price-to-earnings compar analysi yield pt valu share use forward price-to-earnings multipl
analysi look price-to-earnings multipl select biotech pharma compani similar invest profil
alexion compani trade earn offer averag ep compound-annual-growth-rate
project ep compound-annual-growth-rate think l-t sustain franchis light
competit remain concern therefor think share unlik trade premium peer
appli multipl non-gaap ep arriv pt addit forward
revenu multipl in-lin peer also impli share fairli valu
net-present-valu npv analysi support p/e-bas pt includ cash flow alxn base
busi approv product current net cash discount rate termin growth rate
although pt repres upsid current level maintain neutral rate see major
catalyst near intermedi term weak metabol sale patient transit
soliris-to-ultomiri result lower revenu per patient
downsid risk includ failur secur approv soliri nmo slower expect growth mg
upsid risk includ substanti larger expect growth soliri sale nmo larg growth
pnh/ahu popul treatment
page analyst certif import disclosur
compani report guggenheim secur llc estim
page analyst certif import disclosur
inc yatin suneja volum complement qoq total yoy yoy metabol franchis qoq yoy total revenu qoq gross oper oper oper incom non-gaap tax incom loss net incom net gaap qoq yoy ep exclud stock-comp item mm except per share unit
exhibit valuat risk
increas pt base rais price-to-earnings target multipl
rais multipl valu closer highli valu peer biotech compani believ
accur reflect resili eylea franchis continu robust perform dupix strong io pipelin
compani recent describ
pt vs previous assum trade vs prior non-gaap ep
estim support risk-adjust npv vs prior
downsid risk includ failur secur approv eylea/dupixent/libtayo addit indic rapid
complet implement -like seri regul
page analyst certif import disclosur
compani report guggenheim secur llc estim
page analyst certif import disclosur
yatin suneja chang chang product collabor global sale record global sale record global sale record ex-u sale cemiplimab record reimburs includ commerci share antibodi commerci share io commerci collabor eylea row chang chang eylea reimbursements/amort eylea row profit ou licens includ teva research chang collabor zaltrap row eylea non- reimburs non- reimburs teva non- unreimburs stock-bas non- commerci expens reimburst sni sg expens reimburst sg expens non- core stock-bas rate incom net net incom chang chang basic dilut cash per debt per share mm except pre share unit
issu research report guggenheim secur llc guggenheim secur research analyst whose name appear report
herebi certifi view express report accur reflect research analyst person view subject
secur issuer discuss herein ii part research analyst compens directli indirectli relat specif
recommend view express research analyst
research analyst research associ receiv compens base upon variou factor includ qualiti research investor client
feedback guggenheim secur llc overal revenu includ invest bank revenu
guggenheim secur llc affili expect receiv intend seek compens invest bank servic alexion
pharmaceut inc inc next month
pleas refer websit company-specif disclosur referenc report http //guggenheimsecur bluematrix com/sellside/
disclosur action disclosur inform also avail complianc madison avenu new york ny
rate price target histori inc
creat bluematrix
rate price target histori inc
buy describ stock expect provid total return price appreci plu yield within period
neutral describ stock expect provid total return price appreci plu yield plu minu within
sell describ stock expect provid total neg return price appreci plu yield within period
creat bluematrix
page analyst certif import disclosur
